Description and analysis of 12 years of surveillance for Creutzfeldt-Jakob disease in Denmark, 1997 to 2008

Eurosurveillance

Volumn 17, Issue 15, 2012, Pages

  Gubbels, S ^a,b   Bacci, S ^a,b   Laursen, H ^c   Hogenhaven H ^c   Cowan, S ^a   Molbak K ^a   Christiansen, M ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^c Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; GLUTAMIC ACID; METHIONINE; NEURON SPECIFIC ENOLASE; PRION PROTEIN; PROTEIN 14 3 3; SERINE; THREONINE; VALINE;

ADULT; AGED; ARTICLE; AUTOPSY; DENMARK; DISEASE CLASSIFICATION; DISEASE SURVEILLANCE; ELECTROENCEPHALOGRAPHY; FEMALE; GENE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRION PROTEIN GENE; QUESTIONNAIRE; SPORADIC CREUTZFELDT JAKOB DISEASE;

EID: 84862864627     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Tyler KL. Prions and Prion Diseases of the Central Nervous System (Transmissible Neurodegenerative Diseases) - Chapter 175. In: Mandell GL, Bennett JE, Dolan R, editors. Mandell, Douglas and Bennett's principles and practice of infectious diseases 2. New York: Churchill Livingstone; 2005. p. 2219-2235.
2. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347(9006):921-925.
3. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, et al. Transmissions to mice indicate that "new variant" CJD is caused by the BSE agent. Nature. 1997;389(6650):498-501.
4. National Creutzfeldt-Jakob Disease Surveillance Unit (NCJDSU). CJD Statistics. Edinburgh: NCJDRSU. [Accessed 10 Aug 2010]. Available from: http://www.cjd.ed.ac.uk/figures.htm
5. European Creutzfeldt Jakob Disease Surveillance Network. EUROCJD Surveillance Data. Edinburgh: EUROCJD; 2011. Available from: http://www.eurocjd.ed.ac.uk/surveillance%20data%204.htm
6. Strandberg Pedersen N. Mad cows and Creutzfeldt-Jakob Disease. EPI-NEWS. 1997:10. Copenhagen: Statens Serum Institut; 1997.
7. Bahl JMC, Heegaard NHH, Falkenhorst G, Laursen H, Høgenhaven H, Mølbak K, et al. The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease. Neurobiol. Aging. 2009;30(11):1834-1841.
8. Pedersen CB, Gøtzsche H, Møller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 2006;53(4):441-449.
9. Mahillo-Fernandez I, de Pedro-Cuesta J, Bleda MJ, Cruz M, Mølbak K, Laursen H, et al. Surgery and risk of sporadic Creutzfeldt-Jakob disease in Denmark and Sweden: registry-based case-control studies. Neuroepidemiology. 2008;31(4):229-240.
10. World Health Organization. Human transmissible spongiform encephalopathies. Wkly. Epidemiol. Rec. 1998;73(47):361-365.
11. Will RG, Zeidler M, Stewart GE, Macleod MA, Ironside JW, Cousens SN, et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann. Neurol. 2000;47(5):575-582.
12. Mead S. Prion disease genetics. Eur. J. Hum. Genet. 2006;14(3):273-281.
13. Windl O, Giese A, Schulz-Schaeffer W, Zerr I, Skworc K, Arendt S, et al. Molecular genetics of human prion diseases in Germany. Hum. Genet. 1999;105(3):244-252.
14. Population and elections. Copenhagen: Danmarks Statistik; 2011. [Accessed 10 Aug 2010];Available from: http://www.statbank.dk/statbank5a/selecttable/omrade0.asp?SubjectCod e=02&PLanguage=1&ShowNews=OFF
15. Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology. 2005;64(9):1586-1591.
16. Heinemann U, Krasnianski A, Meissner B, Varges D, Kallenberg K, Schulz-Schaeffer WJ, et al. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain. 2007;130(Pt 5):1350-1359.
17. Brandel J-P, Salomon D, Capek I, Vaillant V, Alpérovitch A. Epidemiological surveillance of Creutzfeldt-Jakob in France. Rev. Neurol. (Paris). 2009;165(8-9):684-693. French.
18. Lu C-J, Sun Y, Chen S-S. Incidence of Creutzfeldt-Jakob disease in Taiwan: a prospective 10-year surveillance. Eur. J. Epidemiol. 2010;25(5):341-347.
19. Nakamura Y, Yanagawa H, Hoshi K, Yoshino H, Urata J, Sato T. Incidence rate of Creutzfeldt-Jakob disease in Japan. Int J Epidemiol. 1999;28(1):130-134.
20. Van Everbroeck B, Michotte A, Sciot R, Godfraind C, Deprez M, Quoilin S, et al. Increased incidence of sporadic Creutzfeldt-Jakob disease in the age groups between 70 and 90 years in Belgium. Eur. J. Epidemiol. 2006;21(6):443-447.
21. Ott A, Breteler MM, van Harskamp F, Stijnen T, Hofman A. Incidence and risk of dementia. The Rotterdam Study. Am. J. Epidemiol. 1998;147(6):574-580.
22. Tyler K. Prions and prion diseases of the central nervous system (transmissible neurodegen-erative diseases) In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 6th ed. New York [u.a.]: Churchill Livingstone; 2005.
23. Cooper SA, Murray KL, Heath CA, Will RG, Knight RSG. Isolated visual symptoms at onset in sporadic Creutzfeldt-Jakob disease: the clinical phenotype of the Heidenhain variant. Br J Ophthalmol. 2005;89(10):1341-1342.
24. Wieser HG, Schindler K, Zumsteg D. EEG in Creutzfeldt-Jakob disease. Clin Neurophysiol. 2006;117(5):935-951.
25. Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132(Pt 10):2659-2668.
26. Palmer MS, Dryden AJ, Hughes JT, Collinge J. Homozygous prion protein genotype pre-disposes to sporadic Creutzfeldt-Jakob disease. Nature. 1991;352(6333):340-342.
27. Dyrbye H, Broholm H, Dziegiel MH, Laursen H. The M129V polymorphism of codon 129 in the prion gene (PRNP) in the Danish population. Eur. J. Epidemiol. 2008;23(1):23-27.
28. Shibuya S, Higuchi J, Shin RW, Tateishi J, Kitamoto T. Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 1998;43(6):826-828.
29. Soldevila M, Calafell F, Andrés AM, Yagüe J, Helgason A, Stefánsson K, et al. Prion susceptibility and protective alleles exhibit marked geographic differences. Hum. Mutat. 2003;22(1):104-105.
30. Lee HS, Sambuughin N, Cervenakova L, Chapman J, Pocchiari M, Litvak S, et al. Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease. Am. J. Hum. Genet. 1999;64(4):1063-1070.
31. Hainfellner JA, Brantner-Inthaler S, Cervenáková L, Brown P, Kitamoto T, Tateishi J, et al. The original Gerstmann-Sträussler-Scheinker family of Austria: divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathol. 1995;5(3):201-211.
32. Green AJE, Ramljak S, Müller WEG, Knight RSG, Schröder HC. 14-3-3 in the cerebrospinal fluid of patients with variant and sporadic Creutzfeldt-Jakob disease measured using capture assay able to detect low levels of 14-3-3 protein. Neurosci. Lett. 2002 10;324(1):57-60.
33. Rugbjerg H. Creutzfeldt-Jakobs Disease (CJD). Bovine spongiforme encephalopaty (BSE). EPI-NEWS. 2010:16. Copenhagen: Statens Serum Institut; 2010. [Accessed 16 Aug 2010]. Available from: http://www.ssi.dk/English/News/EPI-NEWS/2010/No%2016%20-%202010.aspx
34. Report on the monitoring and testing of ruminants for the presence of transmissible spongiform encephalopathy (TSE) in the EU in 2008. Brussels: Health and Consumer Protection Directorate-General. Available from: http://ec.europa.eu/food/food/biosafety/tse_bse/docs/annual_report_tse2008_en.pdf
35. Brandel J-P, Heath CA, Head MW, Levavasseur E, Knight R, Laplanche J-L, et al. Variant Creutzfeldt-Jakob disease in France and the United Kingdom: Evidence for the same agent strain. Ann. Neurol. 2009;65(3):249-256.
36. Lillquist PP, Thomas N, Belay ED, Schonberger LB, Morse D. Barriers to autopsy: Creutzfeldt-Jakob disease in New York state. Neuroepidemiology. 2006;26(4):207-211.